Asthma Insurance Claim Denied in New York? Use Your Strong Appeal Rights

New York State has some of the strongest health insurance consumer protections in the country. If your insurer has denied coverage for asthma biologics, a nebulizer, or specialist care, New York's binding External Independent Review: Complete Guide" class="auto-link">external review process means an independent reviewer — not your insurer — gets the final say. Here's how to use that system to your advantage.

Why New York Insurers Deny Asthma Claims

New York insurers deny asthma coverage through familiar, and often unlawful, tactics:

• Step therapy requirements: Demanding patients fail on traditional inhalers before approving FDA-approved biologics like Dupixent, Fasenra, Nucala, or Tezspire
• Prior auth denials for nebulizers and spacers: Calling durable medical equipment "not medically necessary" when prescribed alongside inhalers
• Rescue inhaler quantity restrictions: Limiting albuterol refills even for patients with documented uncontrolled asthma
• Out-of-network specialist denials: Narrow network plans exclude many allergists and pulmonologists, especially in rural upstate New York
• Biologic step therapy loops: Insurers require patients to cycle through multiple biologics sequentially before approving the one their physician selected

New York's Powerful External Review: DFS Binding IME

The New York Department of Financial Services (DFS) oversees health insurance regulation in New York. New York's external review system — called the Independent Medical Review (IME) — is binding on the insurer by state law.

DFS Consumer Assistance:

• Phone: 1-800-342-3736
• Website: dfs.ny.gov
• File a complaint or external review request: dfs.ny.gov/consumers/health

New York's external review is handled by approved IROs) Explained" class="auto-link">Independent Review Organizations (IROs). The process is:

• Standard review: Completed within 30 days
• Expedited review: Completed within 72 hours for urgent situations
• No cost to the patient
• Binding on the insurer: If the IRO finds in your favor, the insurer must cover the treatment

This is one of the strongest external review systems in the nation. Use it.

New York State of Health Marketplace Plans

If you purchased insurance through NY State of Health (NYSOH), New York's ACA marketplace, your plan is subject to full DFS oversight and external review rights. NYSOH plans must comply with New York's step therapy reform law.

New York's Step Therapy Reform Law (2017) — one of the first in the nation — requires insurers to grant step therapy exceptions when:

• The required drug is contraindicated
• The patient previously tried and failed the drug
• The required drug would cause clinically significant adverse effects
• The patient achieved stability on a different medication

To invoke the step therapy exception, your physician submits a formal written request with clinical documentation. Insurers must respond within 3 business days (or 1 day for urgent requests).

New York Medicaid and Asthma Biologics

New York's Medicaid program (managed through NY Medicaid Managed Care plans including MetroPlus, Healthfirst, Fidelis, and Molina) covers FDA-approved asthma biologics for eligible members.

For Medicaid denials:

• Appeal with your managed care plan within 60 days of denial
• Request a Fair Hearing through the NYS Office of Temporary and Disability Assistance (OTDA): 1-800-342-3334
• Aid Continuing: You may be able to continue your current treatment while the hearing is pending — ask your plan about this right

New York-specific asthma burden: The South Bronx has among the highest asthma rates in the entire United States, driven by diesel truck traffic, industrial emissions, and substandard housing. Brooklyn, Harlem, and East New York face similar disparities. If you live in one of these communities, the medical necessity of your asthma treatment is well-documented by public health data.

FDA-Approved Biologics: Building Your Case

When appealing a biologic denial in New York, ensure your physician includes:

• Dupixent (dupilumab): Moderate-to-severe eosinophilic asthma; also approved for atopic dermatitis and nasal polyps, conditions that frequently co-occur with severe asthma in New York patients
• Fasenra (benralizumab): Severe eosinophilic asthma (eosinophils ≥300 cells/μL)
• Nucala (mepolizumab): Severe eosinophilic asthma; COPD with eosinophilic phenotype
• Tezspire (tezepelumab): Uncontrolled severe asthma — no eosinophil threshold, broad phenotype coverage
• Xolair (omalizumab): Allergic asthma with positive skin test or RAST to perennial allergen plus elevated IgE

Ask for a letter that includes eosinophil counts, spirometry results (FEV1), number of exacerbations in the past year, prior medications trialed with outcomes, and an explicit statement of why the requested biologic is clinically appropriate.

Step-by-Step Appeal Process in New York

1. Get the denial in writing: Your insurer must provide a detailed written denial within required timeframes
2. File an internal appeal: Submit within 180 days of the denial date; your plan must decide within 30 days (15 days for urgent)
3. Request peer-to-peer review: Your physician calls the medical director — this step is often decisive
4. Invoke New York's step therapy exception: Submit formal documentation through your insurer's required process
5. File an IME through DFS: After internal appeal exhaustion, request binding external review — this is your strongest tool
6. File a DFS complaint: Complaints are investigated and create regulatory pressure

New York Advocacy Resources

• American Lung Association – New York: lung.org | 1-800-586-4872
• Asthma Coalition of New York: asthmacoalitionny.org — education and policy advocacy
• Community Health Advocates: communityhealthadvocates.org — free help navigating appeals in New York
• Legal Aid Society – Health Law Unit: legalaidnyc.org — free legal representation for Medicaid patients
• New York Legal Assistance Group (NYLAG): nylag.org — insurance appeal assistance

Fight Back With ClaimBack

New York gives you more power to fight insurance denials than almost any other state. ClaimBack helps you use that power effectively — with professionally crafted appeal letters that cite New York's specific laws, your biologic's FDA approval evidence, and your rights under the DFS binding external review system.

Start your appeal at ClaimBack — and make your insurer follow the law.

Related Reading:

• How to Write an Insurance Appeal Letter
• Internal vs. External Insurance Appeal: Which Should You File?
• Insurance Ombudsman Guide